title: [New results of endocrine therapy of breast cancer (the role of Aromasin)].
authors.forename: V F
authors.initials: VF
authors.lastname: Semiglazov
authors.forename: V V
authors.initials: VV
authors.lastname: Semiglazov
authors.forename: A A
authors.initials: AA
authors.lastname: Klemtsel'
authors.forename: N Iu
authors.initials: NIu
authors.lastname: Barash
authors.forename: E K
authors.initials: EK
authors.lastname: Zhil'tsova
authors.forename: A A
authors.initials: AA
authors.lastname: Bozhok
authors.forename: O A
authors.initials: OA
authors.lastname: Mel'nikova
authors.forename: R M
authors.initials: RM
authors.lastname: Paltuev
authors.forename: G A
authors.initials: GA
authors.lastname: Dashian
authors.forename: S G
authors.initials: SG
authors.lastname: Petrovskiĭ
authors.forename: V G
authors.initials: VG
authors.lastname: Ivanov
authors.forename: E E
authors.initials: EE
authors.lastname: Tonuzov
authors.forename: L M
authors.initials: LM
authors.lastname: Berstein
mesh_terms: D000730:Androstadienes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; D013629:Tamoxifen; C056516:exemestane